Navigation Links
Basic research leads to a novel cancer therapy

treated with Sunitinib, compared to the placebo group. Patients with advanced renal cell carcinoma saw a shrinking of the tumour; in 26 to 37 percent of them, the tumour shrunk to at least half its size.

Sunitinib has not yet been approved in Germany, but approval and market entry are expected in this year. Sunitinib is administered after diagnosis. A large number of further clinical studies has shown that Sunitinib has multiple effects on tumour cells and can thus be defined as a novel "multi-targeted" drug.

Sunitinib is being tested now, as well, on patients with advanced forms of bladder cancer, breast cancer, cervical cancer, colon cancer, esophageal cancer, head and neck tumours, liver cancer, lung cancer, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, and testicular cancer. The studies are in various stages of clinical trials (phases I through III), and most of them are being carried out in combination with other therapies.

Ullrich is very pleased with the quick approval of SUTENT®. He says, "Already before approval, 1,700 patients could be treated with the new preparation, thanks to the Accelerated Approval Process. Naturally, we're happy that our research led so quickly to application in cancer therapy. Each year, 390,000 people in Germany alone, and several million worldwide, become ill with cancer. Every fourth death is related to a tumour. We can improve the length and quality of patients' lives by treating them with very specific drugs, which attack a variety of characteristics of tumour cells. Therapy with multi-targeted substances which block signal transduction in tumour cells is a new breakthrough in the war on cancer. They attack critical cancer cell functions in multiple ways and are well tolerated by patients."

This is the second time that Ullrich has played a leading role in the development of a successful cancer therapy. Seven years ago, his research led the breast-cancer therapy Herceptin® to be br
'"/>

Source:Max-Planck-Gesellschaft


Page: 1 2 3 4

Related biology news :

1. Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST)
2. Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
3. Columbia research lifts major hurdle to gene therapy for cancer
4. U of M researcher examines newly emerging deadly disease
5. NYU researchers simulate molecular biological clock
6. First atlas of key brain genes could speed research on cancer, neurological diseases
7. New research questions basic tenet of neuron function
8. Vital step in cellular migration described by UCSD medical researchers
9. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
10. UCSD researchers maintain stem cells without contaminated animal feeder layers
11. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Basic research leads novel cancer therapy

(Date:9/30/2014)... using marijuana, new research, involving mice and published in ... of Leukocyte Biology , suggests that just because ... That,s because a team of Italian scientists have found ... damage to the immune system. This damage may result ... multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis in ...
(Date:9/30/2014)... . , Animals ... such as exposure to predators. Researchers from the Max ... study on different populations of great tits that risk-taking ... High metabolic rates and low temperatures were associated with ... more likely to approach potential predators. , The readiness ...
(Date:9/30/2014)... 2014 Winners of The Economist,s prestigious Innovation ... to take place at the JW Marriott Hong Kong on Friday, ... will share their experiences and the lessons those hold for others. ... innovation over the past decade, will be presented at a ceremony ... summit. It will be the first time the ceremony has come ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Risky metabolism 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... PHILADELPHIA Researchers with the National Cancer Institute (NCI) have ... of breast cancer among women without a personal history of ... the risk of developing breast cancer in women who are ... survey are published in the February issue of Cancer ...
... with a range of different habitat types can help ... conservation, according to new findings published today (8 February ... The research, carried out by scientists from the Centre ... of York, has implications for how we might design ...
... Feb) they have identified for the first time definitive variants ... than 500,000 genetic variations across the entire human genome to ... TERC. The study in Nature Genetics ... King,s College London, working with University of Groningen in the ...
Cached Biology News:Few women take tamoxifen to prevent breast cancer 2Conservation from space: Landscape diversity helps to conserve insects 2Scientists identify first genetic variant linked to biological aging in humans 2
(Date:9/30/2014)... This news release is available in German . ... photonic crystal around several quantum dots in a semiconductor layer. ... a consequence of atomic processes. If a short laser pulse ... modified and the quantum dot experiences a change in the ... slow down the emission of light by the dot. As ...
(Date:9/30/2014)... AMHERST, Mass. Using a bio-mimicking analog of ... of grass, an international research team led by ... has taken a major step in developing long-sought ... to electricity for use in electronic devices. ... UMass Amherst and others at Stanford University and ...
(Date:9/30/2014)... Shimadzu Scientific Instruments has released the DSES-1000 long-travel ... for measuring displacement in rubber and other soft ... distance, the DSES-1000 can measure elongations up to ... mm. In addition, it achieves +/- 0.2 percent ... +/- 100 µm below 50-mm stroke. , The ...
(Date:9/30/2014)... Proove Biosciences , the commercial and research leader in ... test built upon research from their published P.A.I.N. Study. ... physicians with an objective way to understand theirs patient’s ... individuals. With this new test, physicians will be able ... that will affect their pain tolerance. , The P.A.I.N. ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3
... MannKind Corporation,(Nasdaq: MNKD ), focused on discovering, ... it will present at,the Piper Jaffray 20th Annual Health Care ... the New York Palace Hotel in New York City. , ... a link to the live web cast of the,presentation in ...
... MarshallUniversity,s Campus , , HUNTINGTON, ... effort to attract new biotechnology companies and assist them in ... the Huntington Area Development Council (HADCO) is creating a biotech ... West Virginia. , , The ...
... NORWELL, MA, Nov. 25 /PRNewswire/ - EastMed Inc., the ... and wellness, has received FDA clearance to market its ... "We are delighted to get the official ... President of EastMed Inc. "Uresta (TM) Continence Care offers ...
Cached Biology Technology:Huntington Area Development Council Attracts Technology-Based Startup Companies With $150,000 Grant From Verizon West Virginia 2
... Assay, 96 wells. ELISA.Specific for total MMP-3: ... No cross-reactivity with MMP-1, -2, -9. Range: ... with cell culture supernatant, serum, plasma and ... -30 C. Category: Drug Screening & ...
... Dr. P Set from different human ... More organs maybe available upon request. ... items from the whole set, and ... price. All Dr. P Set ...
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Biology Products: